InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
3
T+90 hit rate
50%
T+90 mean return
+20.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Neupert Peter M, Director. Officer active across 4 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 22 filings have been recorded. Breakdown: 3 buys · 3 sells. Total volume traded: €3.4m. Activity tracked since 26 January 2022. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Neupert Peter M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
15,000 shares@ US$6.320.0025% mcap2.7% of flowCommon StockSEC:0001237566-26-000003:0
15,000 shares@ US$25.230.0098% mcap10.7% of flowCommon StockSEC:0001237566-26-000003:1
40,000 shares@ US$25.100.026% mcap28.3% of flowCommon StockSEC:0001237566-26-000003:2
69,690 shares@ US$25.160.045% mcap49.4% of flowCommon StockSEC:0001237566-26-000003:3
15,625 shares0Common StockSEC:0001237566-26-000001:0
897 sharesCommon StockSEC:0000920148-26-000075:0
30,000 shares@ US$6.7940.5% of flowCommon StockSEC:0001127602-25-020326:0
Canonical exit: 6 Nov 2025 (T+90)
7,282 shares0Common StockSEC:0001127602-25-014729:0
50,000 shares@ US$4.0767.7% of flowCommon StockSEC:0001062993-25-005299:0
15,394 shares0Common StockSEC:0001062993-25-004805:0
944 sharesCommon StockSEC:0001127602-25-003708:0
6,354 shares0Common StockSEC:0001127602-24-020751:0
15,000 shares@ US$0.844.2% of flowCommon StockSEC:0001062993-24-006350:0
31,328 shares0Common StockSEC:0001062993-24-005773:0
947 sharesCommon StockSEC:0001127602-24-003890:0
100,000 shares@ US$0.8428.1% of flowCommon StockSEC:0001062993-23-022626:0
11,000 shares@ US$25.296100.0% of flowCommon StockSEC:0001127602-23-023158:0
Canonical exit: 21 Nov 2023 (T+90)
14,775 shares0Common StockSEC:0001062993-23-006335:0
742 sharesCommon StockSEC:0001127602-23-005109:0
1,300 shares@ US$262.85100.0% of flowCommon StockSEC:0001127602-22-005820:0
Canonical exit: 17 May 2022 (T+90)
771 sharesCommon StockSEC:0001127602-22-003412:0
6,689 shares0Common StockSEC:0001209191-22-005495:0
22 of 22 declarations
About Neupert Peter M
NEUPERT PETER M is Administrateur and has filed 18 disclosures in total. In the 18 sampled filings, there were only purchases, for a total of EUR 731417, mainly through option exercises, between 2022-01-28 and 2026-03-06, in relation to Laboratory CORP of America Holdings, Fortrea Holdings Inc. and Adaptive Biotechnologies Corp.
